Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Wooldridge

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Immunology, Immunotherapy : CII|January 22, 1998
T-cell activation induced by anti-CD3 x anti-B-cell lymphoma monoclonal antibody is enhanced by pretreatment of lymphoma cells with soluble CD40 ligandJ E Wooldridge, C E Dahle, G J Weiner
Oncology (Williston Park, N.Y.)|March 17, 2001
Corticosteroids in advanced cancerJ E Wooldridge, C M Anderson, M C Perry
Blood|April 15, 1997
Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphomaJ E Wooldridge, Z Ballas, A M Krieg, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 1997
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunizationG J Weiner, H M Liu, J E Wooldridge, et al.
Leukemia|March 11, 2005
Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicityB Jahrsdörfer, J E Wooldridge, S E Blackwell, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|January 22, 1998
T-cell activation induced by anti-CD3 x anti-B-cell lymphoma monoclonal antibody is enhanced by pretreatment of lymphoma cells with soluble CD40 ligandJ E Wooldridge, C E Dahle, G J Weiner
Oncology (Williston Park, N.Y.)|March 17, 2001
Corticosteroids in advanced cancerJ E Wooldridge, C M Anderson, M C Perry
Blood|April 15, 1997
Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphomaJ E Wooldridge, Z Ballas, A M Krieg, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 1997
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunizationG J Weiner, H M Liu, J E Wooldridge, et al.
Leukemia|March 11, 2005
Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicityB Jahrsdörfer, J E Wooldridge, S E Blackwell, et al.
Pageof 1